Easterly Investment Partners LLC Abb Vie Inc. Transaction History

Easterly Investment Partners LLC

$1.22 Billion
Q3 2024

A detailed history of Easterly Investment Partners LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Easterly Investment Partners LLC holds 6,165 shares of ABBV stock, worth $1.08 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

6,165

Previous 6,172 0.11%

Holding current value

$1.08 Million

Previous $1.06 Million 15.03%

% of portfolio

0.1%

Previous 0.09%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$163.84 - $199.33 $1,146 - $1,395	-7 Reduced 0.11%	6,165 $1.22 Million
Q2 2024 Jul 25, 2024	SELL	$154.79 - $180.76 $598,727 - $699,179	-3,868 Reduced 38.53%	6,172 $1.06 Million
Q1 2024 May 03, 2024	SELL	$159.82 - $182.1 $1.66 Million - $1.89 Million	-10,363 Reduced 50.79%	10,040 $1.83 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $557,417 - $627,783	-4,051 Reduced 16.57%	20,403 $3.16 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $829,593 - $960,376	6,210 Added 34.04%	24,454 $3.65 Million
Q2 2023 Nov 13, 2023	BUY	$132.51 - $164.9 $531,232 - $661,084	4,009 Added 28.16%	18,244 $2.46 Million
Q1 2023 Nov 13, 2023	BUY	$144.61 - $166.54 $189,583 - $218,333	1,311 Added 10.14%	14,235 $2.27 Million
Q1 2023 May 02, 2023	BUY	$144.61 - $166.54 $2.02 Million - $2.32 Million	13,946 Added 131.26%	24,571 $3.92 Million
Q4 2022 Nov 13, 2023	SELL	$138.31 - $165.87 $1.61 Million - $1.93 Million	-11,647 Reduced 47.4%	12,924 $2.09 Million
Q4 2022 Feb 10, 2023	BUY	$138.31 - $165.87 $375,235 - $450,005	2,713 Added 34.29%	10,625 $1.72 Million
Q3 2022 Nov 09, 2022	BUY	$134.21 - $153.93 $56,502 - $64,804	421 Added 5.62%	7,912 $1.06 Million
Q2 2022 Aug 10, 2022	SELL	$137.62 - $174.96 $739,845 - $940,584	-5,376 Reduced 41.78%	7,491 $1.15 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $13.2 Million - $16.3 Million	-99,783 Reduced 88.58%	12,867 $2.09 Million
Q4 2021 Aug 02, 2022	SELL	$107.43 - $135.93 $1.66 Million - $2.1 Million	-15,458 Reduced 12.07%	112,650 $15.3 Million
Q4 2021 Feb 08, 2022	SELL	$107.43 - $135.93 $14.4 Million - $18.2 Million	-134,184 Reduced 51.16%	128,108 $17.3 Million
Q3 2021 Nov 16, 2021	BUY	$106.4 - $120.78 $4.46 Million - $5.07 Million	41,947 Added 19.04%	262,292 $28.3 Million
Q3 2021 Nov 01, 2021	SELL	$106.4 - $120.78 $1.97 Million - $2.24 Million	-18,553 Reduced 7.77%	220,345 $23.8 Million
Q2 2021 Jul 27, 2021	BUY	$105.21 - $117.21 $23.5 Million - $26.2 Million	223,340 Added 1435.53%	238,898 $26.9 Million
Q2 2021 Jul 26, 2021	SELL	$105.21 - $117.21 $24 Million - $26.8 Million	-228,319 Reduced 93.62%	15,558 $1.75 Million
Q1 2021 May 11, 2021	SELL	$102.3 - $112.62 $4.02 Million - $4.42 Million	-39,291 Reduced 13.88%	243,877 $26.4 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $113 Million - $153 Million	-1,405,893 Reduced 83.24%	283,168 $30.3 Million
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $30.5 Million - $35.8 Million	355,428 Added 26.65%	1,689,061 $148 Million
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $48.1 Million - $64.4 Million	-655,850 Reduced 32.97%	1,333,633 $131 Million
Q1 2020 May 13, 2020	BUY	$64.5 - $97.79 $3.63 Million - $5.5 Million	56,255 Added 2.91%	1,989,483 $152 Million
Q4 2019 Feb 11, 2020	SELL	$72.13 - $90.25 $52.2 Million - $65.3 Million	-723,827 Reduced 27.24%	1,933,228 $171 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $91.5 Million - $110 Million	1,452,264 Added 120.54%	2,657,055 $201 Million
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $79.2 Million - $101 Million	1,204,791 New	1,204,791 $87.6 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Easterly Investment Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Easterly Investment Partners LLC with notifications on news.

Account

Easterly Investment Partners LLC Abb Vie Inc. Transaction History